REC-7735 in Participants With Solid Tumors
Study sponsor: Recursion Pharmaceuticals Inc. · RXRX
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2031-01Estimated
Enrollment · participants90Estimated
Source updated2026-09-29Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.